CY1112087T1 - Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα - Google Patents

Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα

Info

Publication number
CY1112087T1
CY1112087T1 CY20111101154T CY111101154T CY1112087T1 CY 1112087 T1 CY1112087 T1 CY 1112087T1 CY 20111101154 T CY20111101154 T CY 20111101154T CY 111101154 T CY111101154 T CY 111101154T CY 1112087 T1 CY1112087 T1 CY 1112087T1
Authority
CY
Cyprus
Prior art keywords
products
rythromycin
procedure
application
new
Prior art date
Application number
CY20111101154T
Other languages
Greek (el)
English (en)
Inventor
Alexis Denis
Giuseppe Gigliotti
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9808795A external-priority patent/FR2780977B1/fr
Priority claimed from FR9905245A external-priority patent/FR2792637B1/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of CY1112087T1 publication Critical patent/CY1112087T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CY20111101154T 1998-07-09 2011-11-24 Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα CY1112087T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9808795A FR2780977B1 (fr) 1998-07-09 1998-07-09 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR9905245A FR2792637B1 (fr) 1999-04-26 1999-04-26 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP99401706A EP0974598B1 (fr) 1998-07-09 1999-07-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments

Publications (1)

Publication Number Publication Date
CY1112087T1 true CY1112087T1 (el) 2015-11-04

Family

ID=26234434

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111101154T CY1112087T1 (el) 1998-07-09 2011-11-24 Νεα παραγωγα της ερυθρομυκινης, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα

Country Status (8)

Country Link
US (1) US6433151B1 (cg-RX-API-DMAC10.html)
EP (1) EP0974598B1 (cg-RX-API-DMAC10.html)
JP (1) JP4573925B2 (cg-RX-API-DMAC10.html)
AT (1) ATE521619T1 (cg-RX-API-DMAC10.html)
CY (1) CY1112087T1 (cg-RX-API-DMAC10.html)
DK (1) DK0974598T3 (cg-RX-API-DMAC10.html)
ES (1) ES2372156T3 (cg-RX-API-DMAC10.html)
PT (1) PT974598E (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE344269T1 (de) * 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
WO2006080954A1 (en) * 2004-07-28 2006-08-03 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
WO2006035301A2 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Erythromycin a derivatives as antibacterial agents
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
SI1836211T1 (sl) * 2004-12-21 2010-04-30 Pfizer Prod Inc Makrolidi
WO2007054904A2 (en) * 2005-11-08 2007-05-18 Ranbaxy Laboratories Limited Macrolides as anti-inflammatory agents
EP1960413A2 (en) * 2005-11-23 2008-08-27 Ranbaxy Laboratories Limited Macrolides derivatives as antibacterial agents
EP1954294A2 (en) * 2005-11-23 2008-08-13 Ranbaxy Laboratories Limited Use of macrolide derivatives for treating acne
WO2007060518A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
PL2102226T3 (pl) * 2006-12-12 2013-01-31 Zambon Spa Związki makrolidowe o aktywności przeciwzapalnej
PE20211551A1 (es) * 2018-12-17 2021-08-16 Lunella Biotech Inc Terapias de combinacion triple para fijar como objetivo mitocondrias y aniquilar celulas madre cancerosas

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725385A (en) * 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
PT876388E (pt) * 1995-11-08 2004-07-30 Abbott Lab Derivados de eritromicina triciclica
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745290B1 (fr) * 1996-02-28 1998-04-03 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
DE69733439T2 (de) 1996-09-04 2006-05-04 Abbott Laboratories, Abbott Park 6-o-Substituierte Ketoliden mit antibakteriellen Wirkung
CA2303930A1 (en) * 1997-09-30 1999-04-08 Abbott Laboratories 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity

Also Published As

Publication number Publication date
EP0974598A2 (fr) 2000-01-26
EP0974598B1 (fr) 2011-08-24
PT974598E (pt) 2011-11-23
JP2000026494A (ja) 2000-01-25
ATE521619T1 (de) 2011-09-15
DK0974598T3 (da) 2011-12-19
EP0974598A3 (fr) 2003-12-17
JP4573925B2 (ja) 2010-11-04
ES2372156T3 (es) 2012-01-16
US6433151B1 (en) 2002-08-13

Similar Documents

Publication Publication Date Title
ES2085130T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion, y su aplicacion como medicamentos.
FR2518088B1 (fr) Nouveaux derives d'aminoacides, et leur application therapeutique
DK0731085T3 (da) Stilbenderivater og farmaceutiske sammensætinger indeholdende disse
TR199902593T2 (xx) �kame edilmi� fenil t�revleri, bunlar�n haz�rlanmas� ve kullan�m�.
YU37098A (sh) Novi derivati eritromicina, postupci za njihovo pripremanje i njihova primena kao medikamenata
CY1112274T1 (el) Νεοι ολιγοσακχαριτες, η παρασκευh τους και οι φαρμακευτικες συνθεσεις οι οποιες τους περιεχουν
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
NO308848B1 (no) Kromanforbindelse og farmasøytisk preparat som inneholder den
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
EA200100983A1 (ru) Производные 13-метилэритромицина
YU13396A (sh) N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima
DK0974598T3 (da) Hidtil ukendte erythromcinderivater, fremgangsmådetil fremstillingheraf og anvendelse heraf som lægemidler
ATE169637T1 (de) Derivate des dolastatin
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
NO981393L (no) Guanidinoproteasehemmere
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
CY1106396T1 (el) Γραμμικες ή κυκλικες ουριες, μεθοδος παρασκευης αυτων και φαρμακευτικες συνθεσεις οι οποιες τις πepιεχουν
ATE155127T1 (de) Benzamid-derivate
CY1112050T1 (el) Νεα 2-αλογονοποιημενα παραγωγα της 5-0- δεσοσαμινυλερυθρονολιδης α, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα
DK0424194T3 (da) Benzanilider
ECSP941031A (es) Derivados de timosina alfa 1
TR199801196T2 (xx) Biyolojik aktif benzotiyazolon etanaminler.
NO994104L (no) 5-hydroksymetyl-2-aminotetraliner i form av kardiovaskulaere midler
EE02942B1 (et) Metüülpiperasinoasepiini derivaadid, nende valmistamine ja kasutamine